Changes in the plasma levels of protein C system parameters in pregnancy

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 7-8, 2003, Pages 481-488

  Vodnik, T ^a   Ignjatovic S ^a   Majkic Singh N ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Activated protein C; Placental thrombosis; Pregnancy; Protein C resistance

Indexed keywords

ACTIVATED PROTEIN C; PROTEIN C; PROTEIN S;

ADULT; ARTICLE; BLOOD CLOTTING TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GESTATIONAL AGE; HEMOSTASIS; HUMAN; MATERNAL HYPERTENSION; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SPONTANEOUS ABORTION; THROMBOSIS;

ABORTION, HABITUAL; ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; BLOOD COAGULATION FACTORS; FEMALE; HUMANS; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY TRIMESTERS; PROTEIN C; PROTEIN S; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 1642471782     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310002905     Document Type: Article

References (33)

1. de Boer K, ten Cate JW, Sturk A, Borm JJJ, Treffers PE. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95-100.
2. Stirling Y, Woolf I, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176-82.
3. Bremme K, Ostlund E, Almqvist I, Heinonen K, Blomback M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992; 80: 132.
4. Halligan A, Bonnar J, Sheppard B. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and preeclampsia. Br J Obstet Gynaecol 1994; 101: 488.
5. Cadroy Y, Boneu B. Coagulation in normal pregnancy and gestosis. Diagnos Labor 1994; 44: 86-94.
6. Walker ID. Thrombophilia in pregnancy. J Clin Pathol 2000; 53: 573-80.
7. Rosen SB, Sturk A. Activated protein C resistance - a major risk factor for thrombosis. Eur J Clin Chem Biochem 1997; 35: 501-16.
8. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-8.
9. Dahlback B. Physiological anticoagulation: resistance to activated protein C and venous thromboembolism. J Clin Invest 1994; 94: 923-7.
10. Bertina RM, Koeleman RPC, Koster T. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
11. Bertina RM, Reitsma PH, Rosendaal FR, Vandenbroucke JP. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995; 74: 449-53.
12. Koster T, Rosendaal FR, Briet E, van der Meer FJM. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997; 78: 631-5.
13. Lockwood CJ. Inherited thrombophilias in pregnancy patients: detection and treatment paradigm. Obstet Gynecol 2002; 99: 333-41.
14. Cumming AM, Tait RC, Fildes S, Yoong A, Keeney S, Hay CRM. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90: 725-7.
15. Hellgren M, Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995; 173: 210-3.
16. Bennet L, Odeberg H. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism. J Intern Med 1998; 244: 27-32.
17. Clark P, Sattar N, Walker ID, Greer IA. The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance. Thromb Haemost 2001; 85: 30-5.
18. Brenner B, Mandel H, Lanir N, Younis J, Rothbart H, Ohel G, Blumenfeld Z. Activated protein C resistance can be associated with recurrent fetal loss. Br J Haematol 1997; 97: 551-4.
19. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996; 92: 489-90.
20. Ridker PM, Miletic JP, Buring JE, Ariyo AA, Price DT, Manson JE, Hill JA. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998; 128: 1000-3.
21. Paternoster DM, Stella A, Simioni P, Girolami A, Snijders D. Activated protein C resistance in normal and pre-eclamptic pregnancies. Gynecol Obstet Invest 2002; 54: 145-9.
22. Grandone E, Margaglione M, Colaizzo D, Daddedda M, Cappucci G, Vecchione G, Scianname N, Pavone G, Diminno G. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost 1997; 77: 822-4.
23. Gemmati D, Serino ML, Scapoli GL. A modified functional global test to measure protein C, protein S activities and the activated protein C resistance phenotype. Thromb Res 1998; 92: 141-8.
24. Dati F, Hafner G, Erbes H. Kraus M, Niemann F, Noah M, Wagner C. Pro C®Global: The first functional screening assay for the complete protein C pathway. Clin Chem 1997; 43: 1719-23.
25. Bauer EL. Statistical methods for chemists. UK: Academic Press; 1971. p. 71-93.
26. Ignjatović S. Biohemijski parametri akutnog pankreatitisa: analitička i klinička vrednost. Doktorska disertacija. Farmaceutski fakultet. Univerzitet u Beogradu, 1997.
27. Zveig MH, Campbell G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39/4: 561-77.
28. Clark P, Brennand J, Conkie JA, McCall, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998 Jun; 79: 1166-70.
29. Mathonnet F, de Mazancourt P, Bastenaire B, Benattar N. Activated protein C sensitivity ratio in pregnant women at delivery. Br J Haematol 1996; 92: 244-6.
30. Manning RM, Letsky EA, Nelson-Piercy C, Peek MJ, de Swiet M. Activated protein C resistance in normal pregnancy. Br J Haematol 1997; 104: 1084-6.
31. Shu H, Wramsby M, Bokarewa M, Blomback M, Bremme K. Decrease in protein C inhibitor activity and acquired APC resistance during normal pregnancy. J Thromb Thrombolysis 2000; 9: 277-81.
32. Benedetto C, Marozio L, Tavella AM, Maula V, Carmignani D, Curti. Response to activated protein C decreases throughout pregnancy. Acta Obstet Gynecol Scand 2002; 81: 1028-32.
33. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285-93.